How One Study Helped Save Free Preventive Care in a Supreme Court Showdown
A 2024 Study Showing How Even Small Copays Reduce PrEP Use Fueled Media, Legal, and Advocacy Efforts As Courts Weighed a Case Threatening No-Cost Preventive Care for Millions
In Their Own Words
FDA Boosted Florida’s Drug Import Plan From Canada, But the Canadians and Big Pharma Probably Won’t Play Along
There Are Better Ways to Achieve These Goals, an LDI Expert Writes
Print:
The following excerpt is from an op-ed that first appeared in MedPage Today on February 24th, 2024.
If you head to the Florida beaches for spring break, you will notice that the Canadian Maple Leaf is often present among the flags outside hotels and tourist apartments. The benefit to Florida from the annual migration of snowbirds from the North has long been evident, but now something more unusual may be coming from Canada.
On January 5, the FDA approved (with conditions) a request from Gov. Ron DeSantis (R.-Fla.) to import prescription drugs from Canada, making Florida the first state ever given authority to import prescription drugs from another country. The Florida Medicaid program is likely hard at work now devising a plan to source large quantities of drugs from Canada, where unit prices are often small fractions of the U.S. list price.
This unprecedented plan begs many questions: Why is it happening in the first place? Who will benefit from or be harmed by this practice? Could it spread to other U.S. states?
Read the entire op-ed here.
Author
Mark V. Pauly, PhD
Bendheim Professor Emeritus, Health Care Management, Wharton School; Professor, Economics, School of Arts and Sciences
More on Health Care Access & Coverage
Insurers’ Utilization Management Tools Vary Widely on Anti-Nausea Drugs for Cancer
Chart of the Day: LDI Researchers Report Major Coverage Differences Across ACA and Medicaid Plans, Affecting Access to Drugs That Treat Chemo-Related Nausea
Why You May Have Fewer Health Insurance Choices Than Your Neighbor
Insurers Avoid Counties With Small Populations and Poor Health but a New LDI Study Finds Limited Evidence of Anticompetitive Behavior
Acupuncture Could Fix America’s Chronic Pain Crisis–So Why Can’t Patients Get It?
A Proven, Low-Risk Treatment Is Backed by Major Studies and Patient Demand, Yet Medicare and Insurers Still Make It Hard To Use
Integrated Care Plans Didn’t Boost Medicaid Enrollment for the Poorest Seniors
Chart of the Day: Medicare-Medicaid Plans—Created to Streamline Care for Dually Eligible Individuals—Failed to Increase Medicaid Participation in High-Poverty Communities
Less Postacute Care for Medicare Advantage Beneficiaries Does Not Mean Worse Health
Research Brief: Shorter Stays in Skilled Nursing Facilities and Less Home Health Didn’t Lead to Worse Outcomes, Pointing to Opportunities for Traditional Medicare